Stay updated on Safety Tolerability in IPF Clinical Trial
Sign up to get notified when there's something new on the Safety Tolerability in IPF Clinical Trial page.

Latest updates to the Safety Tolerability in IPF Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded a Locations section featuring the Pennsylvania site (Hershey, PA). Removed the HHS Vulnerability Disclosure link and updated the page to revision v3.3.3.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2 on the page.SummaryDifference0.1%

- Check49 days agoChange DetectedThe funding-status notice in the page footer has been removed.SummaryDifference0.4%

- Check63 days agoChange DetectedNo significant changes detected in the Study Details page for NCT02503657; the core information about the IPF trial remains unchanged.SummaryDifference0.5%

- Check92 days agoChange DetectedThe page has updated from a no-results state to a results-submitted state (v3.1.0 to v3.2.0) and now includes a government-funding/status notice, indicating active operation and where to verify current status.SummaryDifference3%

- Check99 days agoChange DetectedNew version tag v3.1.0 added and several MedlinePlus topics removed (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs); older version tag v3.0.2 removed. Core page content and topic scope updated accordingly.SummaryDifference0.5%

Stay in the know with updates to Safety Tolerability in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Tolerability in IPF Clinical Trial page.